Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer

Part of paid clinical trials in Atlantis, Florida.

Sponsor
Gustave Roussy, Cancer Campus, Grand Paris
Study ID
NCT00002823
Phase
PHASE3
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 75 Years
Healthy Volunteers
Not accepted

Interventions

  • cisplatin — DRUG
  • etoposide — DRUG
  • vinblastine sulfate — DRUG
  • vindesine — DRUG
  • vinorelbine tartrate — DRUG
  • radiation therapy — RADIATION

Study Details

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known if combination chemotherapy given after surgery is more effective than surgery alone for non-small cell lung cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of combination chemotherapy following surgery with that of surgery alone in treating patients who have stage I, stage II, or stage IIIA non-small cell lung cancer.

Key Dates

Start date
Feb 28, 1995
Status verified
Apr 2011
Primary completion
Jan 31, 2001

Study Design

Enrollment
3,300 participants (estimated)
Allocation
RANDOMIZED
Primary purpose
TREATMENT

Locations (2)

FacilityCityStateZIPSite coordinators
Comprehensive Cancer Center at JFK Medical CenterAtlantisFlorida33462-
Massachusetts General Hospital Cancer CenterBostonMassachusetts02114-

Find similar trials in Atlantis, FL

By condition
Lung cancer
By specialty
OncologyLung oncologyLung disease
By research site
Comprehensive Cancer Center at JFK Medical Center· Atlantis, FLMassachusetts General Hospital Cancer Center· Boston, MA

Related Studies